Expert scientists and clinicians, who are dedicated to understanding prostate cancer, come together through the Institute for Prostate Cancer Research (IPCR) to devise therapies and new technologies in hopes of one day finding a cure.
The institute is a collaborative effort of UW Medicine and
Fred Hutchinson Cancer Research Center
. A natural outgrowth of established research and clinical collaborations, the IPCR brings together a world-renowned team whose mission is to understand the causes of prostate cancer and its progression, develop new prevention strategies, devise innovative diagnostics and improve survival and quality of life.
The IPCR calls on the strength of more than 40 scientists and scientist-clinicians in multiple disciplines. Many are international leaders in their fields.
Together these researchers have already identified and/or assembled up to 80 percent of the genes expressed in prostate cancer, developed one of the largest serum and tissue banks in the world, undertaken some of the most advanced studies of bone biology and skeletal metastases, assembled information and genotypes for more than 300 families with hereditary prostate cancer, and developed many new therapeutic strategies.
Since the IPCR’s formation, its faculty members have been awarded more than $40 million in research grants from the National Institutes of Health and other federal agencies. This includes one of only 10 prostate cancer
Specialized Program of Research Excellence (SPORE)
grants nationwide from the
National Cancer Institute
to study prostate cancer progression.
IPCR faculty members also have received many other individual grants to study numerous aspects of prostate cancer. Receiving this level of private and federal funding constitutes a tremendous accomplishment and demonstrates the excellence of our faculty members and their work.
Together, these scientists and clinicians provide hope for men with prostate cancer and their families in the Northwest and the world.
For cutting-edge news on prostate cancer and regular updates on IPCR progress,
like us on Facebook.
The 2013 Prostate Cancer Survivors Celebration Breakfast: A Big Success!
General Colin Powell, USA (Ret.), keynote speaker and prostate cancer survivor — along with a roomful of other survivors and advocates — helped raise approximately $1.3 million at the Survivors Celebration Breakfast. The breakfast, which supports the Institute for Prostate Cancer Research, was held Thursday, Dec. 5, 2013. Watch the following videos related to the event and IPCR.
Prostate Cancer: The Kids’ Point of View
When Hannah Fleischmann took the stage at the 2013 Survivors Celebration Breakfast on Dec. 5, 2013, she wanted to tell the audience how kids feel when a parent has cancer. There’s anger, there’s helplessness, there’s fear. But she ended her moving speech with hope. “I want a cure,” says Hannah. “Not only for my dad, but for my brother.”
Prostate Cancer and the Promise of Precision Medicine
Researchers at the Institute for Prostate Cancer Research (IPCR) explain how they plan to use precision medicine to defeat prostate cancer.
Conquering Fear, Summoning Hope
The diagnosis of prostate cancer is scary — and life-changing. See how five UW Medicine/Seattle Cancer Care Alliance patients and their families have dealt with diagnosis and treatment — and what they hope for the future.